| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |